Results 51 to 60 of about 39,799 (70)
Some of the next articles are maybe not open access.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
New England Journal of Medicine, 2021Nikolaus Marx +2 more
exaly
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
New England Journal of Medicine, 2022Erasmus Bachus, John McMurray
exaly
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
New England Journal of Medicine, 2021Bertram Pitt, Nikolaus Marx, Marco Metra
exaly
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
New England Journal of Medicine, 2020Nadia Giannetti
exaly
Acute lymphocytic leukemia mimicking renal failure
Ca-A Cancer Journal for Clinicians, 1979Lucius F Sinks
exaly
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
New England Journal of Medicine, 1999Bertram Pitt +2 more
exaly
Catheter Ablation for Atrial Fibrillation with Heart Failure
New England Journal of Medicine, 2018Luc Jordaens
exaly
Long-Term Trends in the Incidence of and Survival with Heart Failure
New England Journal of Medicine, 2002Ramachandran S. Vasan, Joanne M Murabito
exaly
Heart failure with reduced ejection fraction
Nature Reviews Disease Primers, 2017Javed Butler, Barry Greenberg
exaly
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
New England Journal of Medicine, 2019Sergey Boytsov
exaly